沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 12-19 16:08:47

3.930

+0.000

0.00%

最高4.000	最低3.870	成交量35.00万
今开3.940	昨收3.930	日振幅3.31%
总市值26.27亿	流通市值26.29亿	总股本6.69亿
成交额137.43万	换手率0.05%	流通股本6.69亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":3.93,"timestamp":1734595727022,"preClose":3.93,"halted":0,"volume":350000,"delay":0,"floatShares":669000000,"shares":668517808,"eps":-0.61988014,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"12-19 16:08:47","open":3.94,"high":4,"low":3.87,"amount":1374330,"amplitude":0.033079,"askPrice":3.94,"askSize":2000,"bidPrice":3.93,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":-0.39697308866114056,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1589472000000,"adjPreClose":3.93,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":1.097867,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996/wiki","defaultTab":"wiki","newsList":[{"id":"2492122914","title":"药明康德：子企业拟2000万欧元认购私募基金份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2492122914","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492122914?lang=zh_cn&edition=full","pubTime":"2024-12-19 20:47","pubTimestamp":1734612446,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1100","BK0216","603259","EURmain","BK1222","LU1046422090.SGD","LU0320764599.SGD","MEURmain","02359","LU2045819591.USD","161726","399441","BK1574","LU0052750758.USD","09996","159883","LU1997245094.SGD","LU2242644610.SGD","FXE","LU0708995583.HKD","LU2488822045.USD","BK1576","LU0456842615.SGD","EUO","LU1997245177.USD","BK1583","LU2125910500.SGD","09997","BK1141"],"gpt_icon":0},{"id":"2492412858","title":"科华生物(002022.SZ)两款产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492412858","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492412858?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:48","pubTimestamp":1734605333,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司全资子公司科华(西安)生物工程有限公司收到陕西省药品监督管理局颁发的医疗器械注册证。涉及产品：“超高效液相色谱串联质谱系统”、“超高效液相色谱串联质谱系统”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227196.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002022","BK0046","09997","09996","BK1574","BK1583","BK1222","BK0028","BK1100","BK0239","159883","BK0188"],"gpt_icon":0},{"id":"2492656144","title":"业绩减速苗头初现，锦波生物难留在舒适圈","url":"https://stock-news.laohu8.com/highlight/detail?id=2492656144","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492656144?lang=zh_cn&edition=full","pubTime":"2024-12-19 17:22","pubTimestamp":1734600160,"startTime":"0","endTime":"0","summary":"作为北交所的明星公司，锦波生物堪称行业典范，业绩前几年稳定高增长，股价最大涨幅超过15倍，盈利水平之高被市场称为“超越茅台的公司”。在医美赛道整体偏弱的情况下，锦波生物独树一帜。不过，从半年报看出，锦波生物旗下主力产品薇旖美收入同比增幅较去年同期出现明显放缓，并且这个赛道中还有巨子生物、江苏吴中、创建医疗等一大批竞争对手，要维持高毛利的同时还要抢占市场，锦波生物能留在舒适圈的时间还有多久？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/247339","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["09997","02367","09996","LU2488822045.USD","BK1583","BK1100","BK1207","BK1222","BK1574"],"gpt_icon":0},{"id":"2492433771","title":"东方生物(688298.SH)获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492433771","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492433771?lang=zh_cn&edition=full","pubTime":"2024-12-19 16:16","pubTimestamp":1734596198,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方生物 发布公告，公司全资子公司美国衡健生物科技有限公司近日取得毒品尿杯联合检测试剂的美国食品药品监督管理局FDA510许可证;东方生物的新冠/甲乙流抗原三联检试剂近日取得欧盟IVDR注册证书。东方生物新冠/甲乙流抗原三联检试剂在欧盟取得IVDR证书，完善了欧盟市场呼吸道联合检测产品的产品种类，有利于应对常态化、季节性的呼吸道疾病的检测需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688298","BK1583","BK0239","BK1222","BK1574","BK1100","09997","159883","09996"],"gpt_icon":0},{"id":"2492173112","title":"微信称主动打击12万余个售假直播间，处罚3.2万名售假主播","url":"https://stock-news.laohu8.com/highlight/detail?id=2492173112","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492173112?lang=zh_cn&edition=full","pubTime":"2024-12-19 15:14","pubTimestamp":1734592491,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0328353924.USD","LU1226288170.HKD","159883","LU1196710351.USD","IE00B8L5B284.USD","LU0594300419.USD","LU0072913022.USD","00700","BK1609","HTCD.SI","80700","IE00B031HY20.USD","IE0003851619.USD","LU0589944569.HKD","LU2279701549.SGD","TCEHY","LU0880133367.SGD","LU0898667661.SGD","LU1303224171.USD","LU1316542783.SGD","LU0320764755.SGD","LU0348735423.USD","LU0359201885.HKD","LU0608807433.USD","LU0871576103.HKD","IE00B8HQ1Z84.USD","LU1956131251.USD","IE00B5MMRT66.SGD","LU0821914370.USD","LU1769817096.USD","LU1981816686.USD","LU1770036033.HKD","LU0029874905.USD","LU0831103253.SGD","SG9999001226.SGD","SG9999001903.USD","LU0348825331.USD","LU1023057109.AUD","LU0049112450.USD","LU0080751232.USD","LU2097828631.EUR","09997","LU1282649141.HKD","LU0054450605.USD","SG9999006597.SGD","09996","LU0287142896.SGD","LU0541502299.USD","LU0516423091.SGD","LU0214875030.USD"],"gpt_icon":0},{"id":"2492078789","title":"兴齐眼药：公司持续聚焦眼科领域，坚持专业化发展道路，暂无眼科相关的医疗器械研发、生产和销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2492078789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492078789?lang=zh_cn&edition=full","pubTime":"2024-12-18 20:00","pubTimestamp":1734523216,"startTime":"0","endTime":"0","summary":"证券之星消息，兴齐眼药(300573)12月18日在投资者关系平台上答复投资者关心的问题。投资者：董秘你好，公司有无眼科相关的医疗器械研发、生产和销售兴齐眼药董秘：尊敬的投资者您好，公司持续聚焦眼科领域，坚持专业化发展道路，暂无眼科相关的医疗器械研发、生产和销售。未来公司将根据自身发展情况结合公司战略，制定产业延伸和协同发展策略。感谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800035359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0177","BK1583","BK1222","09996","300573","BK1574","BK1100","BK0239","09997"],"gpt_icon":0},{"id":"2492904688","title":"欧普康视最新公告：硬性接触镜验配试纸获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492904688","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492904688?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:30","pubTimestamp":1734521436,"startTime":"0","endTime":"0","summary":"欧普康视公告，近日收到安徽省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，公司的“硬性接触镜验配试纸”产品已完成注册并获得医疗器械注册证。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800034091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK0251","300595","09996","159883","BK1583","BK1100","BK1222","BK1574"],"gpt_icon":0},{"id":"2492901494","title":"欧普康视(300595.SZ)：硬性接触镜验配试纸获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492901494","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492901494?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:20","pubTimestamp":1734520822,"startTime":"0","endTime":"0","summary":"智通财经APP讯，欧普康视(300595.SZ)公告，公司近日收到安徽省药品监督管理局颁发的《医疗器械注册证》，公司的“硬性接触镜验配试纸”产品已完成注册并获得医疗器械注册证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1222","09996","300595","BK1574","159883","BK1100","BK0251","BK1583"],"gpt_icon":0},{"id":"2492909411","title":"长春高新(000661.SZ)下属公司获得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492909411","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492909411?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:01","pubTimestamp":1734519695,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)发布公告，近日，公司下属公司上海赛增医疗科技有限公司收到上海市药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂)。产品名称：促黄体生成素检测试剂盒(荧光免疫层析法)，该产品用于体外定量检测人体尿液样本中促黄体生成。该产品医疗器械注册证的取得，进一步丰富了公司产品线，将对公司业务发展具有正面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0075","BK1583","BK0057","000661","BK0028","BK0239","BK1222","BK0046","BK1574","BK1100","09997","159883","09996"],"gpt_icon":0},{"id":"2492019519","title":"4款创新医疗器械获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2492019519","media":"赛柏蓝器械","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492019519?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:38","pubTimestamp":1734518280,"startTime":"0","endTime":"0","summary":"2024年12月18日，NMPA官网显示，国家药品监督管理局批准了长沙慧维智能医疗科技有限公司的“肠息肉电子下消化道内窥镜图像辅助检测软件”、上海微创旋律医疗科技有限公司的“旋磨介入治疗仪”和“一次性使用冠脉旋磨导管”以及湖南埃普特医疗器械有限公司的“一次性使用磁电定位压力监测脉冲电场消融导管”四个创新产品注册申请。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-18/doc-inczwuet7691558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","09996","159883","BK1222","BK1583","BK1100","BK1574"],"gpt_icon":0},{"id":"2492590632","title":"长春高新最新公告：下属公司上海赛增医疗科技有限公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492590632","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492590632?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:29","pubTimestamp":1734517777,"startTime":"0","endTime":"0","summary":"长春高新公告，公司下属公司上海赛增医疗科技有限公司收到上海市药品监督管理局颁发的《医疗器械注册证》（体外诊断试剂）。产品名称为促黄体生成素检测试剂盒(荧光免疫层析法)，注册证号为沪械注准20242400432，有效期为2024年12月13日至2029年12月12日。该产品用于体外定量检测人体尿液样本中促黄体生成素(LH)的含量，主要用于评价垂体内分泌功能。该产品医疗器械注册证的取得将对公司业务发展具有正面影响，但公司目前无法预测其对未来营业收入的影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800032685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661","159891","BK1100","BK1574","09997","09996","BK0046","BK0239","BK1583","BK0028","BK0057","BK0075","BK0188","BK1222","159883"],"gpt_icon":0},{"id":"2492908363","title":"科华生物(002022.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492908363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492908363?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:54","pubTimestamp":1734515654,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科华生物(002022.SZ)公告，公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证(体外诊断试剂)，相关产品名称为：人类CYP2D6基因多态性检测试剂盒(荧光PCR法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1583","002022","BK0188","BK0028","BK1222","09996","BK1574","BK0046","BK1100","BK0239","09997"],"gpt_icon":0},{"id":"2492977698","title":"达安基因(002030.SZ)：遗传性耳聋基因检测试剂盒取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492977698","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492977698?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:22","pubTimestamp":1734513742,"startTime":"0","endTime":"0","summary":"智通财经APP讯，达安基因 发布公告，近日，公司取得国家药品监督管理局颁发的医疗器械注册证一个，该医疗器械为：遗传性耳聋基因检测试剂盒，注册证编号：国械注准20243402614。有效期自批准之日起至2029年12月16日。预期用途：本试剂盒用于体外定性检测新生儿干血斑样本基因组DNA中4个遗传性耳聋基因中的17个位点，包括GJB2、GJB3、SLC26A4和线粒体12SrRNA基因突变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","09997","BK0168","BK0028","BK0188","09996","BK1583","BK0122","BK0239","BK1100","BK1574","BK0046","BK0159","159883","002030","BK0042"],"gpt_icon":0},{"id":"2492971977","title":"达安基因最新公告：取得遗传性耳聋基因检测试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492971977","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492971977?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:20","pubTimestamp":1734513615,"startTime":"0","endTime":"0","summary":"达安基因公告，公司近日取得国家药品监督管理局颁发的医疗器械注册证一个，具体为遗传性耳聋基因检测试剂盒（PCR-流式荧光杂交法），注册证编号：国械注准20243402614，有效期自批准之日起至2029年12月16日。该试剂盒用于体外定性检测新生儿干血斑样本基因组DNA中4个遗传性耳聋基因中的17个位点突变。上述医疗器械注册证的取得丰富了公司的产品组合，拓宽了公司产品的应用领域。目前，上述产品尚处于市场开发阶段，市场需求存在不确定性。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800029460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1222","159883","BK1583","09996","BK0046","BK0159","BK0188","BK0122","BK0239","002030","BK0028","BK1574","BK0168","BK0042","BK1100"],"gpt_icon":0},{"id":"2492997225","title":"心脉医疗最新公告：控股子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492997225","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492997225?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:58","pubTimestamp":1734512312,"startTime":"0","endTime":"0","summary":"心脉医疗公告，公司控股子公司上海蓝脉医疗科技有限公司获得国家药品监督管理局颁发的医疗器械注册证，产品名称为外周球囊扩张导管，注册证编号为国械注准20243032576，有效期为2024年12月16日至2029年12月15日，注册分类为III类。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800028713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","09996","159883","BK1222","688016","BK1583","BK0251","BK1100","BK1574"],"gpt_icon":0},{"id":"2492974538","title":"心脉医疗(688016.SH)子公司获得外周球囊扩张导管医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492974538","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492974538?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:47","pubTimestamp":1734511668,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)发布公告，近日，公司的控股子公司上海蓝脉医疗科技有限公司获得国家药品监督管理局颁发的关于外周球囊扩张导管的医疗器械注册证，该产品适用于外周血管系统，包括髂动脉和髂股静脉的经皮腔内血管成形术以及用于自体或人工动静脉透析瘘的阻塞性病变的治疗，该产品同样适用于支架和覆膜支架在上述外周血管中的术后扩张。上述产品医疗器械注册证的获得，进一步丰富了公司现有产品种类，扩充公司在外周静脉领域的产品线布局，进一步推动公司在外周领域的市场拓展，不断满足市场需求，促使公司整体销售收入以及利润稳步增长，进一步加深公司在主动脉及外周血管介入市场的影响力及竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0251","688016","BK1583","BK1222","09996","BK1574","BK1100","09997"],"gpt_icon":0},{"id":"2492097195","title":"汇宇制药：全资子公司药品取得多国上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2492097195","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492097195?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:37","pubTimestamp":1734511074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09997","BK1222","159883","BK1583","688553","09996","BK1574","BK1100","BK0239"],"gpt_icon":0},{"id":"2492342971","title":"新华医疗最新公告：公司及子公司产品获二类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492342971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492342971?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:16","pubTimestamp":1734509788,"startTime":"0","endTime":"0","summary":"新华医疗公告，公司及子公司新华手术器械有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》。具体产品包括脉动真空清洗消毒器和医用气腹机。脉动真空清洗消毒器主要用于对手术器械、微创外科器械等的清洗、消毒和干燥，医用气腹机适用于腹腔内窥镜手术中气腹建立和维持。这些产品的注册丰富了公司产品线，有利于提升公司的核心竞争力。但产品上市后实际销售情况取决于市场推广效果，目前尚无法预测对公司未来经营业绩的具体影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800027271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK0188","09996","159883","BK1222","BK1583","BK0251","600587","BK1100","BK1574","BK0028"],"gpt_icon":0},{"id":"2492976221","title":"惠泰医疗(688617.SH)获得一次性使用磁电定位压力监测脉冲电场消融导管医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492976221","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492976221?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:57","pubTimestamp":1734508637,"startTime":"0","endTime":"0","summary":"智通财经APP讯，惠泰医疗(688617.SH)发布公告，公司全资子公司湖南埃普特医疗器械有限公司取得一项医疗器械注册证，产品名称为一次性使用磁电定位压力监测脉冲电场消融导管。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226466.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1583","BK1100","BK1574","159883","BK0251","BK1222","688617","09997"],"gpt_icon":0},{"id":"2492976577","title":"戴维医疗(300314.SZ)全资子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492976577","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492976577?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:55","pubTimestamp":1734508538,"startTime":"0","endTime":"0","summary":"戴维医疗(300314.SZ)公告，公司全资子公司宁波维尔凯迪医疗器械有限公司于近...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/16.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/16.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300314","09997","BK0251","BK0048","09996","BK0042","BK0046","159883","BK1583","BK1100","BK1222","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":-0.0101},{"period":"3month","weight":0.3599},{"period":"6month","weight":0.297},{"period":"1year","weight":-0.437},{"period":"ytd","weight":-0.4682}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Peijia Medical Ltd是一家主要从事介入手术医疗器械研发业务的中国控股公司。通过其子公司，该公司主要运营两个业务部门。经导管瓣膜治疗业务部门主要从事研发经导管瓣膜治疗医疗器械业务。神经介入业务部门从事研发神经介入手术医疗器械业务。该公司的主要在研产品包括TaurusOne、TaurusElite和TaurusNXT等。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087602},{"month":2,"riseRate":0.5,"avgChangeRate":0.022444},{"month":3,"riseRate":0.25,"avgChangeRate":-0.199645},{"month":4,"riseRate":0.666667,"avgChangeRate":0.038325},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.097949},{"month":6,"riseRate":0.6,"avgChangeRate":0.060135},{"month":7,"riseRate":0.4,"avgChangeRate":-0.009656},{"month":8,"riseRate":0.4,"avgChangeRate":-0.07565},{"month":9,"riseRate":0.4,"avgChangeRate":0.044113},{"month":10,"riseRate":0.6,"avgChangeRate":0.006613},{"month":11,"riseRate":0.4,"avgChangeRate":-0.010563},{"month":12,"riseRate":0.6,"avgChangeRate":0.072664}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}